Mahmood Naderi
5PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 09, 2023
Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy.Masoud Sotoudeh, Vahid Mansouri, Ramin Shakeri
|Jul 27, 2022
Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study.Fatemeh Ghafouri, Reza Ahangari Cohan, Hilda Samimi
|Mar 24, 2022
Interpatient variability in mesothelin expression necessitates its evaluation before gastric cancer immunotherapy.Masoud Sotoudeh, Vahid Mansouri, Ramin Shakeri
|Sep 15, 2019
ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy.Masoud Sotoudeh, Ramin Shakeri, Sanford M Dawsey
|Sep 28, 2018
MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma.Masoud Sotoudeh, Seyed Iman Shirvani, Shahin Merat
Pageof 1
